Despite major differences in severity and clinical presentation between EBS (predominantly characterized by epidermal blistering8) and RDEB, both subtypes show skin inflammation with IL‐1ß being a key player in the respective pathologies. This evidence concerns the gene IL1B and recessive dystrophic epidermolysis bullosa.